EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

De novo enhancer deletion of LMX1B produces a mild nail‐patella clinical phenotype

David Francis, Paula Lall, Samantha Ayres, Nicole J Van Bergen, John Christodoulou, Natasha J Brown, Paul Kalitsis

Clinical Genetics · 2024

DOI: 10.1111/cge.14447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von David Francis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Australia. Hauptthemen laut MEDLINE: Genes, Homeobox, Nails. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Victorian Government's Operational Infrastructure Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical genes involved in embryonic development are often transcription factors, regulating many downstream genes. LMX1B is a homeobox gene that is involved in formation of the limbs, eyes and kidneys, heterozygous loss‐of‐function sequence variants and deletions cause Nail‐Patella syndrome. Most of the reported variants are localised within the gene's coding sequence, however, approximately 5%–10% of affected individuals do not have a pathogenic variant identified within this region. In this study, we present a family with four affected individuals across two generations with a deletion spanning a conserved upstream LMX1B‐binding sequence. This deletion is de novo in the mother of three affected children. Furthermore, in this family, the manifestations appear limited to the nails and limbs, and therefore may reflect an attenuated phenotype of the classic Nail‐Patella phenotype that includes ophthalmological and renal manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, HomeoboxNailsChildHumansHomeodomain ProteinsMutationPatellaPhenotypeTranscription FactorsLIM-Homeodomain Proteins

Stichwörter der Autor:innen

LMX1Bdeletionenhancernail-patella syndrome

Substanzen

Homeodomain ProteinsTranscription FactorsLIM homeobox transcription factor 1 betaLIM-Homeodomain Proteins

Autor:innen und Institutionen

  • Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Australia.
  • Department of Paediatrics, University of Melbourne, The Royal Children's Hospital, Parkville, Australia.
  • Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Parkville, Australia.

Förderung

  • Victorian Government's Operational Infrastructure Support Program

Zitieren

APA

Francis, D., Lall, P., Ayres, S., Van Bergen, N. J., Christodoulou, J., Brown, N. J., & Kalitsis, P. (2024). De novo enhancer deletion of LMX1B produces a mild nail‐patella clinical phenotype. Clinical Genetics. https://doi.org/10.1111/cge.14447

Vancouver

Francis D, Lall P, Ayres S, Van Bergen NJ, Christodoulou J, Brown NJ, et al. De novo enhancer deletion of LMX1B produces a mild nail‐patella clinical phenotype. Clinical Genetics. 2024. doi:10.1111/cge.14447

BibTeX
@article{Francis2024,
  author = {Francis, David and Lall, Paula and Ayres, Samantha and Van Bergen, Nicole J and Christodoulou, John and Brown, Natasha J and Kalitsis, Paul},
  title = {De novo enhancer deletion of LMX1B produces a mild nail‐patella clinical phenotype},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14447}
}
Kostenlos starten →